The FDA approved a new drug to treat sickle cell anemia, giving hope to the 100,000 Americans diagnosed with the lifelong disease. This drug is the first new treatment that has been approved for sickle cell disease in the past 20 years. The drug, crizanlizumab, is produced by Novartis and is clinically proven to reduce […]
